NAP 226-90 CAS: 139306-10-8
MF: C10H15NO
MW: 165.23
A metabolite of Rivastigmine, which is a brain selective acetylcholinesterase inhibitor.

NAP 226-90 (CAS 139306-10-8)

NAP 226-90 | CAS 139306-10-8 is rated 5.0 out of 5 by 1.
  • y_2021, m_1, d_15, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_219332, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 167ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Application: NAP 226-90 is a metabolite of Rivastigmine, which is a brain selective acetylcholinesterase inhibitor
CAS Number: 139306-10-8
Purity: ≥99%
Molecular Weight: 165.23
Molecular Formula: C10H15NO
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

NAP 226-90 is an S-Enantiomer metabolite of Rivastigmine, which is a brain selective AChE (acetylcholinesterase) inhibitor.


References

Rosler, M., et al.: Br. Med. J., 318, 633 (1999), Jann, M., et al.: Clin. Pharmacokinet., 41, 719 (2002), Frankfort, S., et al.: Int. J. Clin. Pract., 60, 646 (2006),

Physical State :
Solid
Solubility :
Soluble in chloroform, DMSO, methanol, and water (slightly).
Storage :
Store at 4° C
Melting Point :
111-114° C
Boiling Point :
241.34° C at 760 mmHg (Predicted)
Density :
1.02 g/cm3 (Predicted)
Refractive Index :
n20D 1.54 (Predicted)
Optical Activity :
α20/D -57.14°, c = 0.85 in methanol; α20/D -55.5°±2.5°, c = 1 in methanol (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
PubChem CID :
445892
MDL Number :
MFCD06656491
SMILES :
C[[email protected]](N(C)C)C1=CC=CC(O)=C1

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 139ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from NAP 226 NAP 226-90 is a metabolite of Rivastigmine that acts as a selective acetylcholinerase inhibitor in the brain; its use is cited in various publications. -SCBT Publication Review
Date published: 2015-07-12
  • y_2021, m_1, d_15, h_16
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.12
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_219332, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 5ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.